Design and synthesis of AApeptides: a new class of peptide mimics

Bioorg Med Chem Lett. 2011 Mar 1;21(5):1469-71. doi: 10.1016/j.bmcl.2011.01.005. Epub 2011 Jan 7.

Abstract

A new family of peptide mimics termed 'AApeptides', which are oligomers of N-acylated-N-aminoethyl amino acids, was proposed. The design and efficient synthesis of AApeptides are described. As proof-of-the-concept, we show that AApeptides can inhibit p53/MDM2 protein-protein interaction with significant activity (IC(50)=38 μM) and specificity. Preliminary data also demonstrates that AApeptides are resistant to enzymatic hydrolysis. With the ease of synthesis and diversification, potent bioactivity, and resistance to proteolysis, the development of sequence-specific AApeptides may expand the potential biomedical applications of peptidomimetics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Design*
  • Inhibitory Concentration 50
  • Molecular Structure
  • Peptides / chemical synthesis*
  • Peptides / chemistry
  • Peptides / pharmacology
  • Peptidomimetics*
  • Proto-Oncogene Proteins c-mdm2 / antagonists & inhibitors
  • Tumor Suppressor Protein p53 / antagonists & inhibitors

Substances

  • Peptides
  • Peptidomimetics
  • Tumor Suppressor Protein p53
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2